535,857 cases have been registered since the pandemic reached Ukraine. 241,444 people recovered from the disease (+2,633 per 24 hours). 9,603 people deceased (+95 per 24 hours).
Most of the cases over the day were observed in Kyiv (921), Zaporizhya region (868), Kharkiv region (713), Odesa region (692), and Kyiv region (692).
As we reported earlier, the Ukrainian pharmaceutical company has completed clinical trials of Bioven for the treatment of pneumonia caused by the SARS-CoV-2 virus.
"Clinical trials of our drug Bioven (immunoglobulin) have been completed. Clinical trials began in May, 66 patients with severe disease were randomized, nine bases were involved in the study. The study was completed in October," Kostyantyn Yefimenko, head of the Biopharma board of directors, wrote.
According to Yefimenko, the use of Bioven in the complex therapy of pneumonia caused by a coronavirus, in comparison with standard therapy, allows achieving statistically significant advantages. In particular, a decrease in mortality by four times (from 23.6 to 6.25%), a decrease in the average time to the onset of improvement - from nine to five days, a decrease in the time required for hospitalization - by three to five days.